DIMETHYL FUMARATE SANDOZ (Sandoz Pty Ltd)
Product name
DIMETHYL FUMARATE SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
129 (255 working days)
Active ingredients
dimethyl fumarate
Registration type
New generic medicine
Indication
DIMETHYL FUMARATE SANDOZ (modified release capsule) is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.